Pharmaceutical composition comprising brimonidine, and uses thereof
WO2020064843A1
Pharmaceutical composition in the form of a water-in-oil emulsion (w/o) and its uses
WO2019092509A1
Uv device for evaluation of skin conditions
EP3650040A1
Vegf inhibitors for use for preventing and/or treating atopic dermatitis
WO2019072478A1
Specific acetyl-coa carboxylase inhibitors for use in the treatment and/or prevention of acne
EP3651767A1
Methods and compositions for reducing side effects in chemotherapeutic treatments
FR3079232A1
Novel hdac inhibitor squaramide compounds and their uses for treatment of cell t cell lymphomes (ctcl)
WO2018149991A1
Hydroxylated sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma, ror gamma (t)
FR3075794A1
NEW MTOR INHIBITOR COMPOUNDS
FR3075795A1
NEW MTOR INHIBITOR COMPOUNDS
WO2018109155A1
Trpa1 antagonists for use in the treatment of atopic dermatitis
FR3074042A1
Kit for its use in the prevention and / or treatment of side effects related to anticancer therapy
EP3473163A1
Model for evaluation of dermal fillers
EP3474012A1
Method for the generation of a skin organoculture model and skin model
WO2018065384A1
Expression profiles of abc and slc transporters in human and minipig skin, liver and kidney
WO2018060514A1
Methods and compositions combining at least one pattern recognition receptor (prr) agonist with an anti-il10 receptor antibody
WO2018060513A1
Methods and compositions for treating precancerous lesions or cancer comprising tlr/tlr or tlr/clr agonists
WO2018047001A1
Method of identifying reduced activity of hair follicle mediated by reduction in ability of wnt10a to perform wild type function as a protective factor for moderate to severe and related treatment
EP3500156A1
Uv device for smartphone-based evaluation of skin conditions
